1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 19 OCTOBER 2015

Key Pharma News 19 OCTOBER 2015

  • October 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - China To Experience Increased Demand For Biotechnology Innovation Solutions
Industry Trend Analysis - Genomics Becoming Integral Part Of Successful Drug Development
Industry Trend Analysis - BMS Proactively Defending Immuno-oncology Position
Industry Brief - Amicus Therapeutics Completes Acquisition of Scioderm
Industry Brief - Merck KGaA Brand Relaunched
Industry Trend Analysis - California Biosimilar Legislation Is Encouraging But Remains Premature
Industry Brief - Roche To Acquire Adheron Therapeutics
Industry Brief - Novartis Launches Affordable Medicines Portfolio In Kenya
Industry Trend Analysis - Keytruda's Long-Term Performance Outlook In NSCLC Favourable
Industry Trend Analysis - Pharma Industry Will Need To Heed FTC's 'Product Hopping' Warning
Industry Trend Analysis - Etanercept Filing Highlights Sandoz' Early Lead In US Biosimilar Market
Industry Trend Analysis - HCV Market Dynamics Shifting
Industry Brief - FDA Approves Gilead's Letairis In Combination With Tadalafil For PAH
Industry Trend Analysis - Kadcyla Compulsory Licence Request Will Increase Pricing Pressure For Roche
Industry Trend Analysis - Aristada Approval Will Increase Pressure On Otsuka
Industry Trend Analysis - Balancing Protection And Access Essential For EU Biosimilar Market To Succeed
Industry Brief - FDA Grants Ruconest Twelve-Year Reference Product Exclusivity
Industry Trend Analysis - Second-To-Market Status Not Detrimental For Abemaciclib
Industry Trend Analysis - Axovant Sciences' First Trial Targets A Multi-Billion Dollar Market
Industry Brief - Lilly To Terminate Evacetrapib Phase III Trial In ASCVD
Industry Trend Analysis - Long-Term Studies Will Be Key In Differentiating MS Therapies

Table Of Contents

Key Pharma News 19 OCTOBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.